Inhibitory effects of Pycnogenol® on hepatitis C virus replication

Antiviral Research

Volumn 113, Issue , 2015, Pages 93-102

  Ezzikouri, Sayeh ^a,b   Nishimura, Tomohiro ^c   Kohara, Michinori ^d   Benjelloun, Soumaya ^a   Kino, Yoichiro ^c   Inoue, Kazuaki ^e   Matsumori, Akira ^f   Tsukiyama Kohara, Kyoko ^b  

^a Institut Pasteur du Maroc   (Morocco)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c Kikuchi Research Center   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^e SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^f TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Antioxidant; Natural product; Replication; Resistant; ROS

Indexed keywords

HEPATITIS C VIRUS;

ALPHA INTERFERON; ANTIVIRUS AGENT; FLAVONOID; OLIGOPEPTIDE; PROTEINASE INHIBITOR; PYCNOGENOLS; REACTIVE OXYGEN METABOLITE; RIBAVIRIN; TELAPREVIR; VIRUS PROTEIN; VIRUS RNA;

ANIMAL; ANTIVIRAL RESISTANCE; BIOSYNTHESIS; BLOOD; DRUG EFFECTS; DRUG POTENTIATION; HEPACIVIRUS; HEPATITIS C; METABOLISM; MOUSE; PHYSIOLOGY; REPLICON; TRANSGENIC MOUSE; VIROLOGY; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; DRUG SYNERGISM; FLAVONOIDS; HEPACIVIRUS; HEPATITIS C; INTERFERON-ALPHA; MICE; MICE, TRANSGENIC; OLIGOPEPTIDES; PROTEASE INHIBITORS; REACTIVE OXYGEN SPECIES; REPLICON; RIBAVIRIN; RNA, VIRAL; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84914125473     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2014.10.017     Document Type: Article

References (48)

1. American Botanical Council, 2010. Scientific and clinical monograph for Pycnogenol.
2. N. Antaki, A. Craxi, S. Kamal, R. Moucari, S. Van der Merwe, S. Haffar, A. Gadano, N. Zein, C.L. Lai, J.M. Pawlotsky, E.J. Heathcote, G. Dusheiko, and P. Marcellin The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report Liver Int. 30 2010 342 355
3. B.R. Bacon, S.C. Gordon, E. Lawitz, P. Marcellin, J.M. Vierling, S. Zeuzem, F. Poordad, Z.D. Goodman, H.L. Sings, N. Boparai, M. Burroughs, C.A. Brass, J.K. Albrecht, R. Esteban, and H.R. Investigators Boceprevir for previously treated chronic HCV genotype 1 infection N. Engl. J. Med. 364 2011 1207 1217
4. L. Bassit, J. Grier, M. Bennett, and R.F. Schinazi Combinations of 2′-C-methylcytidine analogues with interferon-alpha2b and triple combination with ribavirin in the hepatitis C virus replicon system Antivir. Chem. Chemother. 19 2008 25 31
5. K.J. Blight, J.A. McKeating, and C.M. Rice Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication J. Virol. 76 2002 13001 13014
6. K.J. Cho, C.H. Yun, D.Y. Yoon, Y.S. Cho, G. Rimbach, L. Packer, and A.S. Chung Effect of bioflavonoids extracted from the bark of Pinus maritima on proinflammatory cytokine interleukin-1 production in lipopolysaccharide-stimulated RAW 264.7 Toxicol. Appl. Pharmacol. 168 2000 64 71
7. Y.H. Choi, and G.H. Yan Pycnogenol inhibits immunoglobulin E-mediated allergic response in mast cells Phytother. Res. 23 2009 1691 1695
8. S.H. Choi, S.Y. Kim, K.J. Park, Y.J. Kim, and S.B. Hwang Hepatitis C virus core protein is efficiently released into the culture medium in insect cells J. Biochem. Mol. Biol. 37 2004 735 740
9. T.C. Chou, and P. Talalay Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors Adv. Enzyme Regul. 22 1984 27 55
10. N.S. de Mochel, S. Seronello, S.H. Wang, C. Ito, J.X. Zheng, T.J. Liang, J.D. Lambeth, and J. Choi Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection Hepatology 52 2010 47 59
11. W.Y. Feng, R. Tanaka, Y. Inagaki, Y. Saitoh, M.O. Chang, T. Amet, N. Yamamoto, S. Yamaoka, and Y. Yoshinaka Pycnogenol, a procyanidin-rich extract from French maritime pine, inhibits intracellular replication of HIV-1 as well as its binding to host cells Jpn. J. Infect. Dis. 61 2008 279 285
12. G. Gong, G. Waris, R. Tanveer, and A. Siddiqui Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B Proc. Natl. Acad. Sci. U.S.A. 98 2001 9599 9604
13. J.H. Hoofnagle, and L.B. Seeff Peginterferon and ribavirin for chronic hepatitis C N. Engl. J. Med. 355 2006 2444 2451
14. K. Inoue, T. Umehara, U.T. Ruegg, F. Yasui, T. Watanabe, H. Yasuda, J.M. Dumont, P. Scalfaro, M. Yoshiba, and M. Kohara Evaluation of a cyclophilin inhibitor in hepatitis C virus-infected chimeric mice in vivo Hepatology 45 2007 921 928
15. I.M. Jacobson, J.G. McHutchison, G. Dusheiko, A.M. Di Bisceglie, K.R. Reddy, N.H. Bzowej, P. Marcellin, A.J. Muir, P. Ferenci, R. Flisiak, J. George, M. Rizzetto, D. Shouval, R. Sola, R.A. Terg, E.M. Yoshida, N. Adda, L. Bengtsson, A.J. Sankoh, T.L. Kieffer, S. George, R.S. Kauffman, S. Zeuzem, and A.S. Team Telaprevir for previously untreated chronic hepatitis C virus infection N. Engl. J. Med. 364 2011 2405 2416
16. A. Katsume, Y. Tokunaga, Y. Hirata, T. Munakata, M. Saito, H. Hayashi, K. Okamoto, Y. Ohmori, I. Kusanagi, S. Fujiwara, T. Tsukuda, Y. Aoki, K. Klumpp, K. Tsukiyama-Kohara, A. El-Gohary, M. Sudoh, and M. Kohara A serine palmitoyltransferase inhibitor blocks hepatitis C virus replication in human hepatocytes Gastroenterology 145 2013 865 873
17. P.Y. Ke, and S.S. Chen Hepatitis C virus and cellular stress response: implications to molecular pathogenesis of liver diseases Viruses 4 2012 2251 2290
18. R. Khachatoorian, V. Arumugaswami, S. Raychaudhuri, G.K. Yeh, E.M. Maloney, J. Wang, A. Dasgupta, and S.W. French Divergent antiviral effects of bioflavonoids on the hepatitis C virus life cycle Virology 433 2012 346 355
19. E. Lawitz, A. Mangia, D. Wyles, M. Rodriguez-Torres, T. Hassanein, S.C. Gordon, M. Schultz, M.N. Davis, Z. Kayali, K.R. Reddy, I.M. Jacobson, K.V. Kowdley, L. Nyberg, G.M. Subramanian, R.H. Hyland, S. Arterburn, D. Jiang, J. McNally, D. Brainard, W.T. Symonds, J.G. McHutchison, A.M. Sheikh, Z. Younossi, and E.J. Gane Sofosbuvir for previously untreated chronic hepatitis C infection N. Engl. J. Med. 368 2013 1878 1887
20. H.H. Lee, K.J. Kim, O.H. Lee, and B.Y. Lee Effect of pycnogenol on glucose transport in mature 3T3-L1 adipocytes Phytother. Res. 24 2010 1242 1249
21. G. Levent, A. Ali, A. Ahmet, E.C. Polat, C. Aytac, E. Ayse, and S. Ahmet Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy J. Transl. Med. 4 2006 25
22. S. Li, E.N. Kodama, Y. Inoue, H. Tani, Y. Matsuura, J. Zhang, T. Tanaka, and T. Hattori Procyanidin B1 purified from Cinnamomi cortex suppresses hepatitis C virus replication Antivir. Chem. Chemother. 20 2010 239 248
23. Y.T. Lin, Y.H. Wu, C.K. Tseng, C.K. Lin, W.C. Chen, Y.C. Hsu, and J.C. Lee Green tea phenolic epicatechins inhibit hepatitis C virus replication via cycloxygenase-2 and attenuate virus-induced inflammation PLoS ONE 8 2013 e54466
24. A. Maimoona, I. Naeem, Z. Saddiqe, and K. Jameel A review on biological, nutraceutical and clinical aspects of French maritime pine bark extract J. Ethnopharmacol. 133 2011 261 277
25. A. Matsumori, H. Higuchi, and M. Shimada French maritime pine bark extract inhibits viral replication and prevents development of viral myocarditis J. Card. Fail. 13 2007 785 791
26. D.F. Mercer, D.E. Schiller, J.F. Elliott, D.N. Douglas, C. Hao, A. Rinfret, W.R. Addison, K.P. Fischer, T.A. Churchill, J.R. Lakey, D.L. Tyrrell, and N.M. Kneteman Hepatitis C virus replication in mice with chimeric human livers Nat. Med. 7 2001 927 933
27. K. Mohd Hanafiah, J. Groeger, A.D. Flaxman, and S.T. Wiersma Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence Hepatology 57 2013 1333 1342
28. T. Nishimura, M. Kohara, K. Izumi, Y. Kasama, Y. Hirata, Y. Huang, M. Shuda, C. Mukaidani, T. Takano, Y. Tokunaga, H. Nuriya, M. Satoh, M. Saito, C. Kai, and K. Tsukiyama-Kohara Hepatitis C virus impairs p53 via persistent overexpression of 3beta-hydroxysterol Delta24-reductase J. Biol. Chem. 284 2009 36442 36452
29. I. Ozeki, J. Akaike, Y. Karino, T. Arakawa, Y. Kuwata, T. Ohmura, T. Sato, N. Kamiya, I. Yamada, K. Chayama, H. Kumada, and J. Toyota Antiviral effects of peginterferon alpha-2b and ribavirin following 24-week monotherapy of telaprevir in Japanese hepatitis C patients J. Gastroenterol. 46 2011 929 937
30. L. Packer, G. Rimbach, and F. Virgili Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol Free Radic. Biol. Med. 27 1999 704 724
31. J.F. Perz, and M.J. Alter The coming wave of HCV-related liver disease: dilemmas and challenges J. Hepatol. 44 2006 441 443
32. F. Poordad, J. McCone Jr., B.R. Bacon, S. Bruno, M.P. Manns, M.S. Sulkowski, I.M. Jacobson, K.R. Reddy, Z.D. Goodman, N. Boparai, M.J. DiNubile, V. Sniukiene, C.A. Brass, J.K. Albrecht, J.P. Bronowicki, and S. Investigators Boceprevir for untreated chronic HCV genotype 1 infection N. Engl. J. Med. 364 2011 1195 1206
33. E. Poveda, D.L. Wyles, A. Mena, J.D. Pedreira, A. Castro-Iglesias, and E. Cachay Update on hepatitis C virus resistance to direct-acting antiviral agents Antiviral Res. 108 2014 181 191 10.1016/j.antiviral.2014.05.015
34. G. Quarato, R. Scrima, F. Agriesti, D. Moradpour, N. Capitanio, and C. Piccoli Targeting mitochondria in the infection strategy of the hepatitis C virus Int. J. Biochem. Cell Biol. 45 2013 156 166
35. H. Sakamoto, K. Okamoto, M. Aoki, H. Kato, A. Katsume, A. Ohta, T. Tsukuda, N. Shimma, Y. Aoki, M. Arisawa, M. Kohara, and M. Sudoh Host sphingolipid biosynthesis as a target for hepatitis C virus therapy Nat. Chem. Biol. 1 2005 333 337
36. F. Serejo, I. Emerit, P.M. Filipe, A.C. Fernandes, M.A. Costa, J.P. Freitas, and M.C. de Moura Oxidative stress in chronic hepatitis C: the effect of interferon therapy and correlation with pathological features Can. J. Gastroenterol. 17 2003 644 650
37. H. Shen, A. Yamashita, M. Nakakoshi, H. Yokoe, M. Sudo, H. Kasai, T. Tanaka, Y. Fujimoto, M. Ikeda, N. Kato, N. Sakamoto, H. Shindo, S. Maekawa, N. Enomoto, M. Tsubuki, and K. Moriishi Inhibitory effects of caffeic acid phenethyl ester derivatives on replication of hepatitis C virus PLoS ONE 8 2013 e82299
38. T. Takano, K. Tsukiyama-Kohara, M. Hayashi, Y. Hirata, M. Satoh, Y. Tokunaga, C. Tateno, Y. Hayashi, T. Hishima, N. Funata, M. Sudoh, and M. Kohara Augmentation of DHCR24 expression by hepatitis C virus infection facilitates viral replication in hepatocytes J. Hepatol. 55 2011 512 521
39. T. Takeuchi, A. Katsume, T. Tanaka, A. Abe, K. Inoue, K. Tsukiyama-Kohara, R. Kawaguchi, S. Tanaka, and M. Kohara Real-time detection system for quantification of hepatitis C virus genome Gastroenterology 116 1999 636 642
40. K.D. Tardif, G. Waris, and A. Siddiqui Hepatitis C virus, ER stress, and oxidative stress Trends Microbiol. 13 2005 159 163
41. C. Tateno, Y. Yoshizane, N. Saito, M. Kataoka, R. Utoh, C. Yamasaki, A. Tachibana, Y. Soeno, K. Asahina, H. Hino, T. Asahara, T. Yokoi, T. Furukawa, and K. Yoshizato Near completely humanized liver in mice shows human-type metabolic responses to drugs Am. J. Pathol. 165 2004 901 912
42. D.L. Thomas Global control of hepatitis C: where challenge meets opportunity Nat. Med. 19 2013 850 858
43. P. Voss, L. Horakova, M. Jakstadt, D. Kiekebusch, and T. Grune Ferritin oxidation and proteasomal degradation: protection by antioxidants Free Radic. Res. 40 2006 673 683
44. T. Wakita, T. Pietschmann, T. Kato, T. Date, M. Miyamoto, Z. Zhao, K. Murthy, A. Habermann, H.G. Krausslich, M. Mizokami, R. Bartenschlager, and T.J. Liang Production of infectious hepatitis C virus in tissue culture from a cloned viral genome Nat. Med. 11 2005 791 796
45. G. Waris, A. Livolsi, V. Imbert, J.F. Peyron, and A. Siddiqui Hepatitis C virus NS5A and subgenomic replicon activate NF-kappaB via tyrosine phosphorylation of IkappaBalpha and its degradation by calpain protease J. Biol. Chem. 278 2003 40778 40787
46. G. Waris, J. Turkson, T. Hassanein, and A. Siddiqui Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication J. Virol. 79 2005 1569 1580
47. T. Watanabe, M. Sudoh, M. Miyagishi, H. Akashi, M. Arai, K. Inoue, K. Taira, M. Yoshiba, and M. Kohara Intracellular-diced dsRNA has enhanced efficacy for silencing HCV RNA and overcomes variation in the viral genotype Gene Ther. 13 2006 883 892
48. S. Zibadi, P.J. Rohdewald, D. Park, and R.R. Watson Reduction of cardiovascular risk factors in subjects with type 2 diabetes by Pycnogenol supplementation Nutr. Res. 28 2008 315 320